In the present study we wished to determine the effect of PARP inhibition pharmacologically or PARP-1 knockdown on estrogen-induced growth of the ER positive breast cancer cell line MCF-7 and BT474 and to examine whether the potential effect was related to a modulation of E2-induced PDZK1 expression. The gene discussed is PDZK1; the disease is breast carcinoma.